GSA CAPITAL PARTNERS LLP - HEPION PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$23,000
-92.2%
20,556
-87.2%
0.00%
-93.9%
Q1 2021$296,000
+51.8%
160,775
+80.5%
0.05%
+53.1%
Q4 2020$195,000–89,067–0.03%–
 Download
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders